Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer.

Longitudinal assessment of cfDNA methylation in mPCa patients unveiled dynamic patterns associated with disease progression and therapy administration, thus highlighting the potential of using liquid biopsies to study PCa evolution at a methylomic level.